相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Preliminary results of biodistribution and dosimetric analysis of [68Ga] Ga-DOTAZOL: a new zoledronate-based bisphosphonate for PET/CT diagnosis of bone diseases
Ambreen Khawar et al.
ANNALS OF NUCLEAR MEDICINE (2019)
Biodistribution and post-therapy dosimetric analysis of [177Lu]Lu-DOTAZOL in patients with osteoblastic metastases: first results
Ambreen Khawar et al.
EJNMMI RESEARCH (2019)
In vivo Evaluation of [225Ac]Ac-DOTAZOL for α-Therapy of Bone Metastases
Nina Pfannkuchen et al.
CURRENT RADIOPHARMACEUTICALS (2018)
IDAC-Dose 2.1, an internal dosimetry program for diagnostic nuclear medicine based on the ICRP adult reference voxel phantoms
Martin Andersson et al.
EJNMMI RESEARCH (2017)
Imaging and dosimetry for radium-223: the potential for personalized treatment
Glenn D. Flux
BRITISH JOURNAL OF RADIOLOGY (2017)
Comparative Therapeutic Efficacy of 153Sm-EDTMP and 177Lu-EDTMP for Bone Pain Palliation in Patients with Skeletal Metastases: Patients' Pain Score Analysis and Personalized Dosimetry
Sarika Sharma et al.
FRONTIERS IN MEDICINE (2017)
Novel Radiolabeled Bisphosphonates for PET Diagnosis and Endoradiotherapy of Bone Metastases
Nina Pfannkuchen et al.
PHARMACEUTICALS (2017)
Dosimetry for Lu-177-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer
Andreas Delker et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting 223Ra-dichloride
Massimiliano Pacilio et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Biology of Bone Metastases in Prostate Cancer
Janine Hensel et al.
UROLOGY (2016)
Therapeutic response and side effects of repeated radioligand therapy with 177Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer
Hojjat Ahmadzadehfar et al.
ONCOTARGET (2016)
Bone targeting compounds for radiotherapy and imaging: *Me(III)-DOTA conjugates of bisphosphonic acid, pamidronic acid and zoledronic acid
M. Meckel et al.
EJNMMI RADIOPHARMACY AND CHEMISTRY (2016)
Optimized production and quality control of 68Ga-EDTMP for small clinical trials
Alireza Mirzaei et al.
ANNALS OF NUCLEAR MEDICINE (2015)
Development of a [177Lu]BPAMD Labeling Kit and an Automated Synthesis Module for Routine Bone Targeted Endoradiotherapy
Marian Meckel et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2015)
Pre-therapeutic dosimetry of normal organs and tissues of 177Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer
Levent Kabasakal et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Clinical Efficacy and Safety Comparison of 177Lu-EDTMP with 153Sm-EDTMP on an Equidose Basis in Patients with Painful Skeletal Metastases
Pradeep Thapa et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
177Lu-EDTMP for palliation of pain from bone metastases in patients with prostate and breast cancer: a phase II study
Krishan Kant Agarwal et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Contemporary approaches for imaging skeletal metastasis
David Ulmert et al.
BONE RESEARCH (2015)
Efficacy and Safety of 177Lu-EDTMP in Bone Metastatic Pain Palliation in Breast Cancer and Hormone Refractory Prostate Cancer A Phase II Study
Jie Yuan et al.
CLINICAL NUCLEAR MEDICINE (2013)
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
Ronald Boellaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry
Cecilia Hindorf et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management
Luca Dalle Carbonare et al.
DRUG HEALTHCARE AND PATIENT SAFETY (2010)
Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate
Flavio Forrer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
177Lu-EDTMP:: A viable bone pain palliative in skeletal metastasis
Sudipta Chakraborty et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2008)
Treatment with 90Y- and 177Lu-DOTATOC in patients with metastatic neuroendocrine tumors
Andrea Frilling et al.
SURGERY (2006)
分享论文
